Katarzyna Grab

Katarzyna Grab

Auto-generated profile, based on publicly available information

Katarzyna Grab

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-095, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2024 in Advanced Science
Verified
Journal Article
Open access
MWMarcin Warminski
Marcin Warminski
KGKatarzyna Grab
Katarzyna Grab
KSKacper Szczepanski
Kacper Szczepanski
TSTomasz Spiewla
Tomasz Spiewla
JZJoanna Zuberek
Joanna Zuberek
JJJacek Jemielity
Jacek Jemielity
Chemical modification of messenger RNA (mRNA) has paved the way for advancing mRNA‐based therapeutics. The intricate process of mRNA translation in eukaryotes is orchestrated by numerous proteins involved in complex interaction networks. Many of them bind specifically to a unique structure at the mRNA 5′‐end, called 5′‐cap. Depending on the 5′‐terminal sequence and its methylation pattern, different proteins may be involved in the translation initiation and regulation, but a deeper understanding of these mechanisms requires specialized molecular tools to identify natural binders of mRNA 5′‐end variants. Here, a series of 8 new synthetic 5′‐cap analogs that allow the preparation of RNA molecules with photoreactive tags using a standard in vitro transcription reaction are reported. Two photoreactive tags and four different modification sites are selected to minimize potential interference with cap‐protein contacts and to provide complementary properties regarding crosslinking chemistry and molecular interactions. The tailored modification strategy allows for the generation of specific crosslinks with model cap‐binding proteins, such as eIF4E and Dcp2. The usefulness of the photoreactive cap analogs is also demonstrated for identifying the cap‐binding subunit in a multi‐protein complex, which makes them perfect candidates for further development of photoaffinity labeling probes to study more complex mRNA‐related processes.

6 December 2024 in RNA
Verified
Journal Article
Open access
PDF file
TSTomasz Spiewla
Tomasz Spiewla
KGKatarzyna Grab
Katarzyna Grab
ADAnais Depaix
Anais Depaix
KZKamil Ziemkiewicz
Kamil Ziemkiewicz
MWMarcin Warminski
Marcin Warminski
JKJoanna Kowalska
Joanna Kowalska
IFITs (interferon-induced proteins with tetratricopeptide repeats) are components of the innate immune response that bind to viral and cellular RNA targets to inhibit translation and replication. The RNA target recognition is guided by molecular patterns, particularly at the RNA 5′ ends. IFIT1 preferably binds RNAs modified with the m7G cap-0 structure, while RNAs with cap-1 structure are recognized with lower affinity. Less is known about the propensity of IFIT1 to recognize noncanonical RNA 5′ ends, including hypermethylated and noncanonical RNA caps. Further insights into the structure-function relationship for IFIT1–RNA interactions are needed but require robust analytical methods. Here, we report a biophysical assay for quick, direct, in-solution affinity assessment of differently capped RNAs with IFIT1. The procedure, which relies on measuring microscale thermophoresis of fluorescently labeled protein as a function of increasing ligand concentration, is applicable to RNAs of various lengths and sequences without the need for their labeling or affinity tagging. Using the assay, we examined 13 canonically and noncanonically 5′-capped RNAs, revealing new binding preferences of IFIT1. The 5′ terminal m6A mark in the m7G cap had a protective function against IFIT1, which was additive with the effect observed for the 2′-Oposition (m6Amcap-1). In contrast, an increased affinity for IFIT1 was observed for several noncanonical caps, including trimethylguanosine, unmethylated (G), and flavin-adenine dinucleotide caps. The results suggest new potential cellular targets of IFIT1 and may contribute to broadening the knowledge of the innate immune response mechanisms and the more effective design of chemically modified mRNAs.

24 October 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KGKatarzyna Grab
Katarzyna Grab
MFMateusz Fido
Mateusz Fido
TSTomasz Spiewla
Tomasz Spiewla
MWMarcin Warminski
Marcin Warminski
JJJacek Jemielity
Jacek Jemielity
JKJoanna Kowalska
Joanna Kowalska
Recent years have led to the identification of a number of enzymes responsible for RNA decapping. This has provided a basis for further research to identify their role, dependency and substrate specificity. However, the multiplicity of these enzymes and the complexity of their functions require advanced tools to study them. Here, we report a high-throughput fluorescence intensity assay based on RNA aptamers designed as substrates for decapping enzymes. Using a library of differently capped RNA probes we generated a decapping susceptibility heat map, which confirms previously reported substrate specificities of seven tested hydrolases and uncovers novel. We have also demonstrated the utility of our assay for evaluating inhibitors of viral decapping enzymes and performed kinetic studies of the decapping process. The assay may accelerate the characterization of new decapping enzymes, enable high-throughput screening of inhibitors and facilitate the development of molecular tools for a better understanding of RNA degradation pathways.

18 June 2026 in bioRxiv
Verified
Preprint
Open access
TATrase Aguigam
Trase Aguigam
KGKatarzyna Grab
Katarzyna Grab
JKJoanna Kowalska
Joanna Kowalska
JJJacek Jemielity
Jacek Jemielity
JGJohn D. Gross
John D. Gross
Removal of the 5′ m⁷G cap by the Dcp1/Dcp2 complex commits mRNAs to degradation, yet the mechanisms regulating decapping remain incompletely understood. Here, we identify residue-level determinants within the extended C-terminus of fission yeast Dcp2 that repress activity. Mutations in conserved inhibitory motifs relieve autoinhibition, enhance RNA binding, and bypass the requirement for the activator Edc3. Strikingly, this activation persists within phase-separated condensates, demonstrating that conformational relief in solution is propagated to the dense phase. We further show that long-range interactions between the intrinsically disordered region of Dcp2 and the catalytic core restrict RNA engagement, providing a mechanistic basis for negative regulation. Together, these findings establish that sequence-encoded elements within the Dcp2 C-terminus control catalytic activity and functional output within biomolecular condensates. More broadly, our results reveal that competing interactions encoded within intrinsically disordered regions of proteins are balanced to allosterically tune enzyme activity, providing a general mechanism by which proteins modulate distinct enzymatic functions within biological condensates.

11 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTomasz Spiewla
Tomasz Spiewla
KGKatarzyna Grab
Katarzyna Grab
ADAnais Depaix
Anais Depaix
KZKamil Ziemkiewicz
Kamil Ziemkiewicz
MWMarcin Warminski
Marcin Warminski
JKJoanna Kowalska
Joanna Kowalska
IFIT proteins (interferon-induced proteins with tetratricopeptide repeats) are key components of the innate immune response that bind to viral and cellular RNA targets to inhibit viral translation and replication. The RNA target recognition is guided by molecular patterns, particularly at the RNA 5’ ends. IFIT1 preferably binds RNAs modified with the 7-methylguanosine (m 7 G) cap-0 structure, while RNAs with cap-1 structure are recognized with lower affinity. Less is known about the propensity of IFIT1 to recognize non-canonical RNA 5’ ends, including hypermethylated and non-canonical RNA caps. Deciphering the structure-function relationship for IFIT1-RNA interaction may improve understanding of cellular selection of IFIT targets and guide the design of exogenously delivered therapeutic RNAs, but requires high-throughput and robust analytical methods. Here, we report a biophysical assay for quick, direct, in-solution affinity assessment of differently capped RNAs with IFIT1. The procedure, which relies on measuring microscale thermophoresis (MST) of fluorescently labelled protein as a function of increasing ligand concentration, is applicable to various RNA lengths and sequences without the need for labelling or affinity tagging. Using the assay, we examined thirteen canonically and non-canonically 5’-capped RNAs, revealing new binding preferences of IFIT1. The 5’ terminal m 6 A mark in the m 7 G cap had a protective function against IFIT1, which was additive with the effect observed for the 2’-O position (m 6 A m cap-1). In contrast, an increased affinity for IFIT1 was observed for several non-canonical caps, including trimethylguanosine (TMG), unmethylated (G), and flavin-adenine dinucleotide (FAD) caps. The results suggest new potential cellular targets of IFIT1 and may contribute to broadening the knowledge on the mechanisms of the innate immune response as well as the more effective design of chemically modified mRNAs.